Nebulization versus injection in ambulatory treatment of acute asthma: a comparative study
- PMID: 2978461
- DOI: 10.1016/0007-0971(88)90087-3
Nebulization versus injection in ambulatory treatment of acute asthma: a comparative study
Abstract
Nebulization treatment of acute asthma with terbutaline and ipratropium bromide, given either separately with a 30-minute interval or combined as single inhalation, was compared with injection treatment with a combination of terbutaline given subcutaneously and theophylline given intravenously. Seventy-seven episodes of acute asthma were studied. Nebulization treatment gave the same degree of bronchodilation as the injections, both immediately after treatment [measured as increase in forced expiratory volume in 1 second (FEV1) in peak expiratory flow rate (PEFR) and improvement of dyspnoea] and during the following 6 days (measured by PEFR recordings at home). The injection treatment caused a moderate increase in heart rate, whereas no circulatory side-effects were noted during nebulization treatment. Administration of ipratropium bromide 30 minutes after terbutaline was not more effective than the combination of both substances as a single nebulization.
Similar articles
-
Comparison of inhaled terbutaline and inhaled terbutaline plus ipratropium bromide in acute asthmatic children.Asian Pac J Allergy Immunol. 1990 Jun;8(1):45-8. Asian Pac J Allergy Immunol. 1990. PMID: 2144115
-
Use of ipratropium bromide in patients with severe airways obstruction.Aust N Z J Med. 1982 Feb;12(1):38-43. doi: 10.1111/j.1445-5994.1982.tb02423.x. Aust N Z J Med. 1982. PMID: 6211167 Clinical Trial.
-
Response to nebulized ipratropium bromide and terbutaline in acute severe asthma.Respir Med. 1992 May;86(3):215-8. doi: 10.1016/s0954-6111(06)80058-2. Respir Med. 1992. PMID: 1535717
-
[Pulmonary function tests with the bronchodilator Terbutaline].Acta Med Austriaca Suppl. 1979;14:1-39. Acta Med Austriaca Suppl. 1979. PMID: 161461 Review. German.
-
International expert opinion on the use of nebulization for pediatric asthma therapy during the COVID-19 pandemic.J Thorac Dis. 2021 Jul;13(7):3934-3947. doi: 10.21037/jtd-21-841. J Thorac Dis. 2021. PMID: 34422324 Free PMC article. Review. No abstract available.
Cited by
-
Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD001284. doi: 10.1002/14651858.CD001284.pub2. Cochrane Database Syst Rev. 2017. PMID: 28076656 Free PMC article.
-
Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD010256. doi: 10.1002/14651858.CD010256. Cochrane Database Syst Rev. 2012. PMID: 23235686 Free PMC article.
-
Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD010179. doi: 10.1002/14651858.CD010179. Cochrane Database Syst Rev. 2012. PMID: 23235685 Free PMC article.